NYSE:ABC - AmerisourceBergen Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$92.17 +0.60 (+0.66 %)
(As of 06/20/2018 06:00 AM ET)
Previous Close$92.17
Today's Range$90.39 - $92.18
52-Week Range$71.90 - $106.27
Volume1.16 million shs
Average Volume1.23 million shs
Market Capitalization$20.13 billion
P/E Ratio14.65
Dividend Yield1.66%
Beta1.02
AmerisourceBergen logoAmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:ABC
CUSIP03073E10
Phone610-727-7000

Debt

Debt-to-Equity Ratio1.38
Current Ratio0.94
Quick Ratio0.48

Price-To-Earnings

Trailing P/E Ratio14.65
Forward P/E Ratio14.27
P/E Growth1.39

Sales & Book Value

Annual Sales$153.14 billion
Price / Sales0.13
Cash Flow$8.0148 per share
Price / Cash11.50
Book Value$9.47 per share
Price / Book9.73

Profitability

EPS (Most Recent Fiscal Year)$5.88
Net Income$364.48 million
Net Margins0.57%
Return on Equity51.04%
Return on Assets3.83%

Miscellaneous

Employees20,000
Outstanding Shares219,800,000

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Thursday, May 10th. Shareholders of record on Monday, May 21st will be given a dividend of $0.38 per share on Monday, June 4th. This represents a $1.52 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend is Friday, May 18th. View AmerisourceBergen's Dividend History.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) issued its earnings results on Wednesday, May, 2nd. The company reported $1.96 earnings per share for the quarter, topping analysts' consensus estimates of $1.83 by $0.13. The company earned $41.03 billion during the quarter, compared to the consensus estimate of $40.56 billion. AmerisourceBergen had a net margin of 0.57% and a return on equity of 51.04%. The firm's revenue was up 10.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.77 earnings per share. View AmerisourceBergen's Earnings History.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for AmerisourceBergen.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.45-6.65 for the period, compared to the Thomson Reuters consensus estimate of $6.55. The company issued revenue guidance of +8-11% to ~$165.4-170.0 billion, compared to the consensus revenue estimate of $167.81 billion.

What price target have analysts set for ABC?

16 brokerages have issued 1 year price targets for AmerisourceBergen's stock. Their forecasts range from $87.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $103.0714 in the next twelve months. View Analyst Ratings for AmerisourceBergen.

Who are some of AmerisourceBergen's key competitors?

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the folowing people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
  • Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
  • Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
  • Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
  • Mr. James D. Frary, Exec. Officer (Age 46)

Has AmerisourceBergen been receiving favorable news coverage?

Media coverage about ABC stock has trended somewhat positive on Wednesday, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. AmerisourceBergen earned a daily sentiment score of 0.12 on Accern's scale. They also gave headlines about the company an impact score of 45.99 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.56%), Franklin Resources Inc. (1.76%), Wells Fargo & Company MN (1.30%), Burgundy Asset Management Ltd. (1.24%), FIL Ltd (1.22%) and Northern Trust Corp (1.09%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Lon R Greenberg, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, FIL Ltd, Allen Investment Management LLC, Artisan Partners Limited Partnership, OMERS ADMINISTRATION Corp, Royal Bank of Canada, Franklin Resources Inc. and Thompson Siegel & Walmsley LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, Gina Clark, John G Chou, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was acquired by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Coho Partners Ltd., Wedge Capital Management L L P NC, Mackay Shields LLC, Rock Springs Capital Management LP, DekaBank Deutsche Girozentrale, Caisse DE Depot ET Placement DU Quebec and State of Tennessee Treasury Department. View Insider Buying and Selling for AmerisourceBergen.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $92.17.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $20.13 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]


MarketBeat Community Rating for AmerisourceBergen (ABC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  493 (Vote Outperform)
Underperform Votes:  453 (Vote Underperform)
Total Votes:  946
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.